Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 2068

FDA adcomm raises risk questions on AstraZeneca’s Andexxa

$
0
0
Members of an FDA advisory committee were not asked to vote Thursday on AstraZeneca’s anticoagulant reversal drug Andexxa, but they did raise several safety and efficacy concerns. Last year, AstraZeneca began plans to shift Andexxa ...

Viewing all articles
Browse latest Browse all 2068

Trending Articles